To include your compound in the COVID-19 Resource Center, submit it here.

Takeda ends Japan deal for two Amgen candidates

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) said it returned its Japanese

Read the full 101 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE